Could you please provide some guidance regarding submitting Risk Management Plan for a product that requires significant updates to its SPC?
A product SPC and PIL will be updated which will result in addition of information on to undesirable effects and contraindication. Would this update to SPC and PIL require resubmission of RMP?
Thank you for your query.
Please note that the response to your query represents the opinions formed from a consensus of the PIPA committee, but does not represent their employing companies. These responses are intended as guidance. Please also refer to guidelines and your own company’s procedures.
Where information held by the MAH leads to updated information about the safety profile of a product and where the updated information is called out specifically within the product’s RMP; then the RMP and any associated additional risk minimisation materials (aRMMs) will need to be reviewed and assessment made. If the assessment shows that the benefit risk profile has altered that the RMP and aRMMs will need to be updated.
Updates to the RMP are required where there is a change to the safety information that impacts or alters an important risk (as defined in the EU and UK GVPs) these can be added or removed or the aRMMs modified. Updated versions of these documents will need to be submitted and approved by relevant Competent Authorities.
We do hope that the above answers your query.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.